Logo image of ALBFR.PA

SIDETRADE (ALBFR.PA) Stock Fundamental Analysis

EPA:ALBFR - Euronext Paris - Matif - FR0010202606 - Common Stock - Currency: EUR

213  -2 (-0.93%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to ALBFR. ALBFR was compared to 103 industry peers in the Software industry. ALBFR gets an excellent profitability rating and is at the same time showing great financial health properties. ALBFR is growing strongly while it is still valued neutral. This is a good combination! These ratings could make ALBFR a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

ALBFR had positive earnings in the past year.
ALBFR had a positive operating cash flow in the past year.
ALBFR had positive earnings in each of the past 5 years.
In the past 5 years ALBFR always reported a positive cash flow from operatings.
ALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

Looking at the Return On Assets, with a value of 10.30%, ALBFR belongs to the top of the industry, outperforming 89.32% of the companies in the same industry.
ALBFR's Return On Equity of 20.04% is amongst the best of the industry. ALBFR outperforms 83.50% of its industry peers.
ALBFR has a Return On Invested Capital of 8.78%. This is in the better half of the industry: ALBFR outperforms 69.90% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALBFR is below the industry average of 11.25%.
The 3 year average ROIC (8.57%) for ALBFR is below the current ROIC(8.78%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.3%
ROE 20.04%
ROIC 8.78%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ALBFR.PA Yearly ROA, ROE, ROICALBFR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

ALBFR has a better Profit Margin (14.36%) than 67.96% of its industry peers.
ALBFR's Profit Margin has improved in the last couple of years.
ALBFR has a better Operating Margin (10.56%) than 62.14% of its industry peers.
ALBFR's Operating Margin has improved in the last couple of years.
ALBFR has a better Gross Margin (75.67%) than 61.16% of its industry peers.
In the last couple of years the Gross Margin of ALBFR has grown nicely.
Industry RankSector Rank
OM 10.56%
PM (TTM) 14.36%
GM 75.67%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
ALBFR.PA Yearly Profit, Operating, Gross MarginsALBFR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALBFR is creating some value.
Compared to 1 year ago, ALBFR has more shares outstanding
ALBFR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALBFR has an improved debt to assets ratio.
ALBFR.PA Yearly Shares OutstandingALBFR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
ALBFR.PA Yearly Total Debt VS Total AssetsALBFR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ALBFR has an Altman-Z score of 7.12. This indicates that ALBFR is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 7.12, ALBFR is doing good in the industry, outperforming 74.76% of the companies in the same industry.
ALBFR has a debt to FCF ratio of 0.92. This is a very positive value and a sign of high solvency as it would only need 0.92 years to pay back of all of its debts.
The Debt to FCF ratio of ALBFR (0.92) is better than 81.55% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that ALBFR is not too dependend on debt financing.
ALBFR has a better Debt to Equity ratio (0.20) than 65.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.92
Altman-Z 7.12
ROIC/WACC1.06
WACC8.27%
ALBFR.PA Yearly LT Debt VS Equity VS FCFALBFR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.55 indicates that ALBFR should not have too much problems paying its short term obligations.
ALBFR has a Current ratio of 1.55. This is in the better half of the industry: ALBFR outperforms 64.08% of its industry peers.
ALBFR has a Quick Ratio of 1.55. This is a normal value and indicates that ALBFR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALBFR (1.55) is better than 66.99% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.55
ALBFR.PA Yearly Current Assets VS Current LiabilitesALBFR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

8

3. Growth

3.1 Past

ALBFR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.62%, which is quite impressive.
Measured over the past years, ALBFR shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.85% on average per year.
Looking at the last year, ALBFR shows a very strong growth in Revenue. The Revenue has grown by 25.69%.
ALBFR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.43% yearly.
EPS 1Y (TTM)40.62%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%22.96%
Revenue 1Y (TTM)25.69%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%31.95%

3.2 Future

ALBFR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.12% yearly.
Based on estimates for the next years, ALBFR will show a quite strong growth in Revenue. The Revenue will grow by 11.57% on average per year.
EPS Next Y10.56%
EPS Next 2Y12.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.68%
Revenue Next 2Y11.19%
Revenue Next 3Y11.57%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALBFR.PA Yearly Revenue VS EstimatesALBFR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALBFR.PA Yearly EPS VS EstimatesALBFR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 40.96 indicates a quite expensive valuation of ALBFR.
ALBFR's Price/Earnings ratio is a bit cheaper when compared to the industry. ALBFR is cheaper than 65.05% of the companies in the same industry.
ALBFR is valuated expensively when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 35.90 indicates a quite expensive valuation of ALBFR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALBFR is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of ALBFR to the average of the S&P500 Index (36.36), we can say ALBFR is valued inline with the index average.
Industry RankSector Rank
PE 40.96
Fwd PE 35.9
ALBFR.PA Price Earnings VS Forward Price EarningsALBFR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

ALBFR's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, ALBFR is valued a bit cheaper than the industry average as 66.99% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 37.29
EV/EBITDA 42.31
ALBFR.PA Per share dataALBFR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALBFR does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of ALBFR may justify a higher PE ratio.
ALBFR's earnings are expected to grow with 12.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.88
PEG (5Y)1.47
EPS Next 2Y12.12%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALBFR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SIDETRADE

EPA:ALBFR (8/6/2025, 7:00:00 PM)

213

-2 (-0.93%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-16 2025-07-16
Earnings (Next)10-14 2025-10-14
Inst Owners18.26%
Inst Owner ChangeN/A
Ins Owners35.29%
Ins Owner ChangeN/A
Market Cap319.50M
Analysts84
Price Target290.7 (36.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.79%
Revenue NY rev (3m)-4.79%
Valuation
Industry RankSector Rank
PE 40.96
Fwd PE 35.9
P/S 5.81
P/FCF 37.29
P/OCF 33.4
P/B 8.11
P/tB 37.03
EV/EBITDA 42.31
EPS(TTM)5.2
EY2.44%
EPS(NY)5.93
Fwd EY2.79%
FCF(TTM)5.71
FCFY2.68%
OCF(TTM)6.38
OCFY2.99%
SpS36.65
BVpS26.27
TBVpS5.75
PEG (NY)3.88
PEG (5Y)1.47
Profitability
Industry RankSector Rank
ROA 10.3%
ROE 20.04%
ROCE 11.95%
ROIC 8.78%
ROICexc 18.16%
ROICexgc N/A
OM 10.56%
PM (TTM) 14.36%
GM 75.67%
FCFM 15.58%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ROICexc(3y)18.44%
ROICexc(5y)20.75%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.66%
ROCE(5y)12.74%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-1.75%
ROICexc growth 5Y5.4%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
F-Score7
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.92
Debt/EBITDA 1.09
Cap/Depr 71.02%
Cap/Sales 1.82%
Interest Coverage 250
Cash Conversion 132.6%
Profit Quality 108.49%
Current Ratio 1.55
Quick Ratio 1.55
Altman-Z 7.12
F-Score7
WACC8.27%
ROIC/WACC1.06
Cap/Depr(3y)191.5%
Cap/Depr(5y)202.1%
Cap/Sales(3y)4.08%
Cap/Sales(5y)4.13%
Profit Quality(3y)97.77%
Profit Quality(5y)121.95%
High Growth Momentum
Growth
EPS 1Y (TTM)40.62%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%22.96%
EPS Next Y10.56%
EPS Next 2Y12.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.69%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%31.95%
Revenue Next Year10.68%
Revenue Next 2Y11.19%
Revenue Next 3Y11.57%
Revenue Next 5YN/A
EBIT growth 1Y-0.02%
EBIT growth 3Y5.13%
EBIT growth 5Y20.49%
EBIT Next Year2.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61.61%
FCF growth 3Y12.94%
FCF growth 5Y37.14%
OCF growth 1Y10%
OCF growth 3Y9.02%
OCF growth 5Y29.8%